Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on May 14, 2007, reporting a significant change in its Board of Directors' leadership. Effective May 11, 2007, the Board elected Jim Manzi, a current director, to the position of Chairman of the Board. This appointment is a key development for the company's governance structure. Mr. Manzi will receive annual cash compensation of $250,000 for his new role as Chairman, which replaces his previous compensation as a regular director, including retainers and meeting fees. This change signals a formalization of leadership at the board level, important for investor confidence and strategic direction.
Key Highlights
- 1Jim Manzi elected as Chairman of the Board, effective May 11, 2007.
- 2Mr. Manzi was a pre-existing director of Thermo Fisher Scientific Inc.
- 3The Chairman role is a newly created or formalized position with dedicated compensation.
- 4The new Chairman will receive annual cash compensation of $250,000.
- 5This compensation replaces prior compensation received as a regular director (retainer and meeting fees).
- 6The filing is an 8-K, indicating a material event affecting the company's governance.
Frequently Asked Questions
The main event reported is the election of Jim Manzi as the new Chairman of the Board of Directors for Thermo Fisher Scientific Inc., effective May 11, 2007.
Jim Manzi is a current director of Thermo Fisher Scientific Inc. For his new role as Chairman of the Board, he will receive annual cash compensation of $250,000. This replaces his previous compensation for serving as a director.
A change in Board leadership, especially the appointment of a Chairman, is significant as it impacts corporate governance and strategic oversight. Investors often look to board composition and leadership for stability, direction, and accountability.
No, the filing explicitly states the election of Jim Manzi as Chairman and does not mention any departures of directors or principal officers.